According to BioNexus Gene Lab's latest financial reports the company's current EPS (TTM) is -0,04127ย โฌ. In 2022 the company made an earnings per share (EPS) of -0,02175ย โฌ a decrease over its 2021 EPS that were of 0,03294ย โฌ.